Leyden Labs’ $70 Million Funding Round

Kennedy Van der Laan acted as legal advisors to lead investors ClavystBio and Polaris Partners.Leyden Labs has raised $70 million to further develop their intranasal antibody…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Georgio Naffaa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here